Helus Pharma
Develops investigational serotonergic therapies for depression and generalized anxiety disorder.
$12.35
After-hours close+0.19 (+1.56%)
At close$12.16(−8.16%)
| Date | Estimate | Reported | Surprise |
|---|---|---|---|
| Nov 2026 | −$0.67 | — | — |
| Aug 2026 | −$0.84 | −$0.91 | −8.8% |
| Jul 2026 | −$0.79 | — | — |
| Jun 2026 | −$1.04 | −$0.96 | +7.8% |
| Jun 2026 | −$1.04 | — | — |
| Feb 2026 | −$0.76 | −$0.99 | −30.5% |
| Feb 2026 | −$0.53 | −$0.72 | −35.8% |
The latest year is open to everyone — the 21 quarters behind it read with an account. Sign in | |||
| Nov 2025 | |||
| Aug 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| Mar 2024 | |||
| Feb 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| Mar 2023 | |||
| Feb 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| Mar 2022 | |||
| Feb 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| Mar 2021 | |||
| Dec 2020 | |||
| Oct 2020 | |||
| Jun 2020 | |||
| Dec 2019 | |||
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise |
|---|---|---|---|---|---|---|
| Nov 12, 2026 | −$0.67 | — | — | — | — | — |
| Aug 14, 2026 | −$0.84 | −$0.91 | −8.8% | — | — | — |
| Jul 1, 2026 | −$0.79 | — | — | — | — | — |
| Jun 30, 2026 | −$1.04 | −$0.96 | +7.8% | $1.3M | $1.3M | 0.0% |
| Jun 29, 2026 | −$1.04 | — | — | — | — | — |
| Feb 16, 2026 | −$0.76 | −$0.99 | −30.5% | — | — | — |
| Feb 13, 2026 | −$0.53 | −$0.72 | −35.8% | — | — | — |
The latest year is open to everyone — the 21 quarters behind it read with an account. Sign in | ||||||
| Nov 13, 2025 | ||||||
| Aug 13, 2025 | ||||||
| Nov 13, 2024 | ||||||
| Aug 8, 2024 | ||||||
| Mar 31, 2024 | ||||||
| Feb 14, 2024 | ||||||
| Nov 15, 2023 | ||||||
| Aug 14, 2023 | ||||||
| Mar 31, 2023 | ||||||
| Feb 14, 2023 | ||||||
| Nov 14, 2022 | ||||||
| Aug 8, 2022 | ||||||
| Mar 31, 2022 | ||||||
| Feb 10, 2022 | ||||||
| Nov 15, 2021 | ||||||
| Aug 16, 2021 | ||||||
| Mar 31, 2021 | ||||||
| Dec 31, 2020 | ||||||
| Oct 31, 2020 | ||||||
| Jun 30, 2020 | ||||||
| Dec 31, 2019 | ||||||